Patents by Inventor Elaine Alison Irving

Elaine Alison Irving has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of stroke comprising anti-MAG antibodies
    Patent number: 8974782
    Abstract: The present invention relates to a dosing regimen for use in the treatment of stroke. More particularly, the invention relates to the administration of two doses of anti-MAG antibodies for the treatment of ischemic and/or haemorrhagic stroke.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: March 10, 2015
    Assignee: Glaxo Group Limited
    Inventors: Bams Abila, Lori Ann Enney, Seth Paul Finklestein, Volker Germaschewski, Robert Ian Grundy, Elaine Alison Irving, Monica Simeoni
  • DOSING REGIMEN
    Publication number: 20120207749
    Abstract: The present invention relates to a dosing regimen for use in the treatment of stroke. More particularly, the invention relates to the administration of two doses of anti-MAG antibodies for the treatment of ischemic and/or haemorrhagic stroke.
    Type: Application
    Filed: February 7, 2012
    Publication date: August 16, 2012
    Applicant: Glaxo Group Limited
    Inventors: Bams ABILA, Lori Ann ENNEY, Seth Paul FINKLESTEIN, Volker GERMASCHEWSKI, Robert Ian GRUNDY, Elaine Alison IRVING, Monica SIMEONI
  • Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies
    Patent number: 8017115
    Abstract: A method of promoting oligodendrocyte survival in a human suffering from, or at risk of developing, stroke or other neurological diseases utilizes anti-MAG antibodies or functional fragments of such antibodies.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: September 13, 2011
    Assignee: Glaxo Group Limited
    Inventors: Elaine Alison Irving, Mary Vinson
  • Antagonists of Myelin-associated Glycoprotein and their use in the treatment and/or prevention of Neurological diseases
    Publication number: 20040170627
    Abstract: A method of treatment or prophylaxis of stroke and other neurological diseases in a human which comprises administering an effective amount of a MAG antagonist or anti-MAG antibody including altered antibodies and functional fragments thereof.
    Type: Application
    Filed: December 17, 2003
    Publication date: September 2, 2004
    Inventors: Elaine Alison Irving, Mary Vinson
  • Use of orexin receptor antagonists
    Patent number: 6506774
    Abstract: The use of orexin receptor antagonists as neuroprotectants, and in the treatment of nausea and vomiting, irritable bowel syndrome and other conditions associated with visceral pain.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: January 14, 2003
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Elaine Alison Irving, Gareth John Sanger